Discover Exceptional performance and protection 1,2 that Continuous Glucose Monitoring delivers. Now in color and better than ever.
Introducing the G4 PLATINUM Continuous Glucose Monitoring System The CGM you ve been waiting for has finally arrived! Color CGM Easy to read and identify glucose highs and lows. 20-Foot Range 3x farther than the next available brand with 97% of expected sensor data captured. 2,5 3 Faceplate Colors Tickled Pink Classic Black Touch of a Button TM Glucose trend on demand. Ocean Blue Sleek, slim, and easy to see. The G4 PLATINUM CGM System offers a modern design and color LCD screen with vibrant colors so you can easily see glucose highs, lows and everything in between to help manage your patients diabetes. Better than ever. Our new G4 PLATINUM sensor packs a punch and delivers even better performance and accuracy 22 than ever for dependable results you and your patients can count on. You re serious about results, so don t settle for just any sensor. Choose the one that delivers dynamic glucose patterns, exceptional sensing performance, and software that makes identifying critical patterns quick and easy. Choose G4 PLATINUM and see the difference. Customized Alarms Alert profiles with tones and melodies to suit your individual needs wherever you are. G4 PLATINUM Continuous Glucose Monitoring System
Fingersticks show current glucose, but do your patients know where their glucose is heading? If this is the meter reading, what would your patients do? 105 If your patients saw this instead, would they have responded differently? How Continuous Glucose Monitoring can help patients make healthy, confident, and well-informed decisions. Whether you re trying to lower your patients A1c, reduce their number of hypo incidents, or keep them out of the ER, Continuous Glucose Monitoring (CGM) gives your patients a complete and real time picture of their glucose levels to help avoid these events 3. Fingersticks alone can only alert you to patterns when you have tested. But with CGM, you ll see where glucose is heading and how fast it s getting there. With the G4 PLATINUM, you can coach your patients to make informed decisions in the short-term while mapping a pathway for long-term better health. A1c (%) 8.0 7.5 7.0 6.5 CGM Lowers A1Cs without increasing hypoglycemia Control P<.001 RT-CGM Baseline 13 weeks 26 weeks Significant Decrease in A1c in Patients Aged 25 Years *Error bars stand for 95% Cl. JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359(14):1464-1476 Widespread Coverage for CGM The majority of commercial insurances have medical policy to cover CGM. can investigate insurance coverage for your patients. -0.53% If this is the meter reading, what would your patients do? 105 If your patients saw this instead, would they have responded differently? Same number. Different decisions. Get the assurance of real time data in vivid colors that only G4 PLATINUM CGM can provide.
Setting an even higher standard in CGM The difference is When it comes to accuracy, s Sensor Geometry, Membrane Technology, and Algorithm are what set us apart. Our commitment to continuously improve our technology enables us to deliver exceptional sensing performance. The results speak for themselves. Software that easily and quickly identifies critical patterns When LOWER is better G4 TM Overall Accuracy Mean ARD % (MARD) 40-400 mg/dl 13% 16% 20% G4 TM Sensor to Sensor Variation Average difference between sensors 9% 15% 17% Menu navigation Enhanced features INTUITIVE New features New pre- and post-meal glucose range customization PORTRAIT the report that says it all! When HIGHER is better G4 TM Hypoglycemia Detection Rate (% of time BG level at/below alert setting and alert sounded within 15 minutes before or after BG value was 70mg/dL) True alert rate 83% 57% 49% Hypoglycemia Accuracy Over Time Within 20 mg/dl of YSI between 40-80 mg/dl G4 TM PLATINUM 11 Day 1: 81% Day 4: 88% Day 7: 81% 2x/day SEVEN PLUS 12 Day 1: 73% Day 4: 76% Day 7: 69% 2x/day Brand M 5 Based on last 12 hours of each day Day 1: 81% Day 2: 65% Day 3: 41% 3.5x/day G4 TM Hypoglycemia Accuracy Within 20 mg/dl of YSI between 40-80 mg/dl 83% 73% 68% G4 TM 94% (7 day sensor) Sensor Life (up to indicated use) 89% (7 day sensor) 55% (3 day sensor) Advanced QUICK PRINT Feature Downloads in seconds Sensor of choice No matter what your patients choice of insulin delivery, CGM can benefit patients on multiple daily injections just as significantly as those on insulin pumps 8. FOCUSED SIMPLIFIED One page report May help validate and prioritize therapy changes Complete CGM interpretation documentation Daily Strip Print for integrated event details with one click Going beyond is the first to develop a CE Marked in-vivo, Automated Blood Glucose Monitoring System in partnership with Edwards Lifesciences for use in the critical care environment. Your patients will thank you Deliver discretion A sleek and slim Receiver profile plus ear-pleasing tones or melodies so your patients can customize their alerts and alarms to suit different environments. Deliver comfort With a sensor needle that s more than 1/3 smaller 6 than the next available brand, it s easy to see why is often cited as the most comfortable sensor to wear. Deliver a sensor that fits their lifestyle is the only sensor on the market that s approved for up to 7 days 2,4 of wear for added value and patient convenience. 2010 2011 2012 Metrics presented are values rounded to the nearest whole number. consistently ranked highest in customer loyalty 3 years in a row. 7 If your patient pumps, G4 PLATINUM can be used to complement their insulin pump to help fine-tune their insulin delivery therapy. Pump Brands Animas Omnipod Roche Tandem Diabetes Care Medtronic 9 Insulin Brands Eli Lilly Novo Nordisk Sanofi In the Artificial Pancreas arena, 10 CGM is a proud partner in the JDRF AP and the European AP@Home studies. AP See for yourself what sets us apart and experience the difference that is. Contact us today at (888) 738-3646 / (858) 200-0200 or visit www.dexcom.com to discover more.
BRIEF SAFETY STATEMENT The G4 PLATINUM Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. CONTRAINDICATIONS: Remove the G4 PLATINUM System before MRI, CT scan, or diathermy treatment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING: Do not use the G4 PLATINUM for treatment decisions. The G4 PLATINUM does not replace a blood glucose meter. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Technical Support. The G4 PLATINUM is not approved for use in children or adolescents, pregnant women or persons on dialysis. Sensor placement is not approved for sites other than under the skin of the belly (abdomen). Contact Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information. 2013 Inc. All rights reserved. This product is covered by US patent. DEXCOM, THE GLUCOSE SENSOR COMPANY, DEXCOM G4 PLATINUM, DEXCOM STUDIO, DEXCOM PORTRAIT, DEXCOM MAKES SENSE., DAILY STRIP PRINT, DESIGNED FOR EXCEPTIONAL SENSING, QUICK PRINT, SMART.SIMPLE.SENSE., and TOUCH OF A BUTTON are trademarks and registered trademarks of, Inc. All trade dress used in connection with products and services appearing herein are property of and protected by United States and foreign trademark laws. All other trademarks and registered trademarks are the property of their respective owners. References: 1 Polonsky W, Hessler D, Bowman F, Price D. Impact of CGM use on Quality of Life (QoL): A survey of current users. ADA Poster, June 2012. 2 G4 PLATINUM User Guide, 2012. 3 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. N Engl J Med. 2008:359(14):1464-1476. 4 SEVEN PLUS User Guide, 2008. 5 Medtronic Paradigm REAL-Time Revel manufacturer User Guide, 2009. 6 DiabetesHealth.com, Product Reference Guide, 2010; Caliper measurements: 0.018, Medtronic 0.028, measurements are in 1/1000th inches, May 2011. 7 dq&a market research study, 2009-2012. 8 Rodbard D, Jovanovic L, Garg SK. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diab Tech Ther. 2009;11:757-763 9 1 in 4 users on pumps use Medtronic, customer survey, April 2012 10 Internal data on file, May 2012. 11 RPT-901776: Effectiveness and Safety of the G4 Continuous Glucose Monitoring System, 2012. 12 RPT-900185: Effectiveness and Safety of the Next-Generation SEVEN Continuous Glucose Monitoring System, 2008. To locate your local representative, call (888) 738-3646 Customer Care: (888) 738-3646 Inc. Corporate Headquarters 6340 Sequence Drive San Diego, CA 92121 (858) 200-0200 www.dexcom.com LBL-011671 Rev03 MT 22216